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Abstract
The session ‘Advancing risk assessment science – Nutrition’ at EFSA’s third Scientiﬁc Conference
‘Science, Food and Society’ aimed to foster the ongoing debate on the extent to which single
nutrients, whole foods and overall diets may impact human health in wealthy populations, and to
explore how societal and technological developments could affect food choices and diets in the future.
The overarching goal of the session was to discuss how dietary guidelines could evolve to account for
the switch from single nutrient deﬁciencies to diseases of malnutrition in all its forms as the
predominant public health concern in developed countries. Speakers addressed the contribution of
single nutrients to the prevalence of chronic metabolic diseases, discussed the need to move towards
diets focusing on whole foods and overall eating patterns, provided insides on food innovation and
consumer behaviour and stressed the need for multidisciplinary approaches to face these challenges.
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1. Introduction
The discovery in the ﬁrst half of last century that insufﬁcient intakes of speciﬁc vitamins could be
the single cause of various diseases of public health concern underpinned the research and policy
agenda in the nutrition area. Research focused on the estimation of nutrient requirements compatible
with prevention of clinical nutrient deﬁciency diseases, on the quantiﬁcation of nutrients in foods, and
on the prevention of hunger. Therefore, policy aimed to ensure adequate provision of speciﬁc isolated
nutrients as well as total calories through agricultural production of staple crops, food processing,
fortiﬁcation and distribution, dietary advice and labelling. Towards the 1980s, overt vitamin and
mineral deﬁciencies became rare in wealthy countries, whereas the prevalence of chronic metabolic
diseases such as obesity, cardiovascular diseases (CVDs) and type 2 diabetes (T2DM) increased
steadily. The leading causes of morbidity and mortality of western populations shifted as a result, and
so did nutrition research.
Consistent with paradigms for treating nutrient deﬁciencies, studies on the prevention of metabolic
cardiometabolic diseases initially focused mainly on single dietary components (e.g. on reducing
intakes of energy, total fat, saturated fats, trans-fats, sugars, sodium; and on increasing intakes of
dietary ﬁbre, potassium). More recently, however, the role of speciﬁc foods and overall dietary patterns
on disease prevention has gained attention, also in the context of other lifestyle modiﬁcations.
This publication builds upon presentations made and discussions held during the breakout session
‘Advancing risk assessment science – Nutrition’ at EFSA’s third Scientiﬁc Conference ‘Science, Food and
Society’ (Parma, Italy, 18–21 September 2018).1
The session aimed to foster the ongoing debate on the extent to which single nutrients, whole
foods and overall diets may impact human health in wealthy populations, and to explore how societal
and technological developments could impact food choices and diets in the future. The overarching
goal of the session was to discuss how dietary guidelines could evolve to address the switch from
nutrient deﬁciencies to diseases of excess as the predominant public health concern in developed
countries.
The speciﬁc objectives of the session were to:
• foster the scientiﬁc debate about whether and how the consumption of two classes of
nutrients, sugars and saturated fats, is causally related to the high prevalence of chronic
metabolic diseases;
• explore the health impact of diets selected by their energy content, the content of a single
nutrient, or personal priorities and beliefs versus the health impact of diets selected on the
basis of whole foods and overall eating patterns;
• understand the role of food innovation on modern diets in response to consumer trends, and
as driver of consumer choices;
• investigate how societal and technological changes could impact food choices of users in post-
industrial societies in the coming years.
2. From single nutrients to whole foods and diets in post-industrial
societies
In the context of Socratic debates, Graham McGregor and John Sievenpiper were invited to argue
in favour and against sugars being one of the nutrients to tackle in the prevention of chronic metabolic
diseases. Ronald Mensink and Philippe Legrand discussed the causal role of saturated fats in chronic
disease development, primarily coronary heart disease (CHD). The aim was to identify reasons for
discrepant views and points of agreement to draw a balanced picture on these matters. Dariush
Mozaffarian provided an overview on how nutrition science has evolved in the last century to
understand why different dietary approaches aiming to prevent chronic metabolic diseases have been
relatively unsuccessful so far and the lessons to be learnt from a scientiﬁc and policymaking
perspective. Finally, Petra Klassen Wigger discussed how socio-demographic changes and consumer
trends in information societies could impact food availability, food choices and dietary patterns, as well
as on the challenges and opportunities that this could create in the journey towards healthier diets.
Below follows a summary of the ideas, statements, opinions and challenges raised by the panellists
during the session.
1 All conference materials are available at https://www.efsa.europa.eu/en/events/event/180918
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2.1. Impact of single nutrients on the prevalence of chronic metabolic
diseases
Sugars and saturated fats have been singled out at different points in time as being responsible for
the increasing epidemic of obesity, CVD and diabetes in afﬂuent societies. Their causal role and
contribution to the development of multifactorial diseases, however, has been long debated in the
scientiﬁc literature. Mass media and social media have highlighted that scientiﬁc debate shapes
different views.
Speakers agreed that unhealthy diets are a major cause of death and preventable disability world-
wide. In wealthy countries, there was consensus that excessive consumption of added sugar and salt
is to be avoided. The questions are how much is too much, whether the food source matters, and
which could be the most effective ways to change consumers’ behaviour. More complexity was evident
on saturated fat, with differences in views depending on the replacement nutrient and type of
saturated fatty acids (SFA).
Arguments in favour of added sugars causing chronic disease focused on sugar-sweetened
beverages (SSBs). Sugar has an unquestionable causal role in caries development. With respect to
obesity, diabetes and fatty liver disease, the effect appears to be at least in part mediated by
overconsumption of SSBs, and so energy, which is not compensated by an increase in physical activity.
Some data from short-term controlled trials keeping energy intake constant do not support an
independent role of sugars in chronic disease development, but this was deemed to be less relevant
because SSBs are rather consumed in free-living conditions and not within energy limits. Other studies
support the independent adverse effects of added sugars, at high dose and ﬂux, on hepatic steatosis,
insulin resistance, associated metabolic abnormalities and metabolic expenditure. Among the possible
ways to address the public health problem of excessive consumption of ‘empty’ calories from SSBs,
particularly by children, taxation, advertisement bans, colour labelling, reduction of portion sizes, step-
wise product reformulation and strict dietary guidelines were mentioned.
Opponents to a causal role of sugars in chronic disease development called for a reformulation of
the question: are sugars, independent of food form and calories, associated with chronic diseases? In
prospective cohort studies, no association has been observed between total sugars, sucrose, or
fructose and the incidence of T2DM, whereas a threshold for an adverse association of total sugars,
added sugars and fructose with CVD outcomes has been reported. There appears to be an
independent positive association between fructose and risk of gout and CVD at high intakes. Positive
dose–response associations have been also described for SSBs and body weight gain, risk of
hypertension, T2DM, cardiovascular death and gout. In contrast, no association or even inverse
associations are found for other sugar-containing foods, such as 100% fruit juice (with no added
sugars), fruits, yogurt, chocolate, ice cream or breakfast cereals. Evidence from randomised controlled
trials (RCTs), which are in principle more protected from bias than observational studies, shows no
adverse effects of fructose on body weight and even a beneﬁcial effect on blood glucose control and
blood pressure when compared to reﬁned starches in eucaloric conditions (substitution trials),
suggesting that a reformulation strategy that replaces fructose-containing sugars with reﬁned starches
is unlikely to be of any beneﬁt. In trials in which sugars are added to the usual diet as a source of
excess calories, however, high intakes of fructose induced body weight gain, insulin resistance, a more
atherogenic blood lipid proﬁle and increases in serum uric acid, plasma glucose and liver fat. Similar
effects have been described for SSBs. Overall, the available evidence suggests that the adverse health
effects of fructose and SSBs are mediated at least partly by their contribution to excess calorie
consumption.
In this context, a risk was raised of blaming sugars as a whole for the chronic disease epidemic,
which may induce consumers to select foods and diets on the basis of the sugar content only, ignoring
other nutritional characteristics. An example of how a narrow dietary strategy for disease prevention
can fail is given by the low-fat paradigm, by which reducing fat intake by increasing availability of low-
fat products in the USA resulted in a parallel increase in the incidence of obesity and related diseases.
Therefore, attention should be paid to the nutritional properties of foods as a whole, rather than their
sugar content alone, shifting from ‘nutricentric’ recommendations to food and dietary pattern-based
guidelines. Panellists agreed that decreasing consumption of SSBs and other liquid sources of ‘empty’
calories was a sensible recommendation to make. It was also discussed that decreasing the sugar
content of solid foods through food reformulation can be challenging in some cases, also because the
nutrient or substance to be used in replacement should be considered carefully: replacing sugars with
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reﬁned complex carbohydrates may not have a positive impact on chronic disease prevention; ﬁbre
would be the preferred alternative, but achieving acceptable palatability could be an issue.
The discussion on saturated fats started with an overview of the speciﬁc physiological functions of
different SFA depending on their chain length. Besides being a source of energy, SFA participate in the
metabolism of n-3 and n-6 polyunsaturated fatty acids (PUFA), in protein acetylation and activation
pathways, and are structural components of sphingolipids and phospholipids, among others. Metabolic
speciﬁcities of some SFAs were described. Whereas endogenously synthesised and perhaps dietary
palmitic acid (C16:0) in cells may induce adverse effects, short- and medium-chain SFA (≤ C10:0; e.g.
butyric acid) and some long-chain SFA (e.g. myristic and lauric acid) do not. Also, dietary stearic acid
(C18:0) desaturates to cis-oleic acid (C18:1) in phospholipids and may partly mimic the metabolic
effects of its monounsaturated derivative.
It was argued that most RCTs available showed adverse effects of SFA on intermediate markers of
disease [e.g. low-density lipoprotein (LDL) cholesterol] rather than on hard CVD outcomes (e.g.
myocardial infarction); that most studies have compared SFA with PUFA without specifying the type of
SFA being investigated; and that prospective cohort studies or meta-analysis on the association
between SFA intake and CHD risk were inconsistent, so that there was no evidence to consider SFA as
a single group of nutrients of public health concern. Adverse metabolic effects have been documented
for palmitic acid if consumed in excess, but excessive consumption of added sugars, reﬁned complex
carbohydrates and alcohol could lead to similar metabolic effects, as these molecules are converted to
palmitic acid by the liver and contribute to the LDL cholesterol load, liver fat accumulation and insulin
resistance. In this context, replacement of palmitic acid with n-3 PUFA was indicated as the option that
could bring the highest health beneﬁts.
Conversely, it was argued that the causal relationship between LDL cholesterol and CHD risk has
convincingly been established to rely on this biomarker of effect, as supported by clinical guidelines on
disease prevention, even if the number of RCTs on hard CVD outcomes is limited. It was emphasised
that the effects of SFA on LDL cholesterol depend on the nutrient that is taken as reference. Stearic
acid decreases LDL cholesterol concentrations as compared with palmitic acid to the same extent as
carbohydrates, but increases LDL cholesterol concentrations as compared with PUFA. In addition, it
was highlighted that fatty acids are found as mixtures in edible oils and fats, and that there are very
few intake data on individual SFA. Such data, however, show that palmitic acid is quantitatively the
main SFA consumed, about two times more than stearic acid, and that the intake of myristic and lauric
acid is lower.
With respect to the apparently conﬂicting observational data on the relationship between SFA
intake and CHD risk, some speakers noted that: (a) estimations of individual habitual intakes of SFA in
prospective cohort studies are likely to be imprecise due to the limitations of the assessment methods
used; and (b) the inﬂuence of dietary factors on LDL cholesterol is relatively small, but not negligible,
compared with genetic and other environmental factors. Therefore, these speakers found it not
surprising that some cohort studies do not show an association between SFA and CHD risk, and
concluded that the effect of a mixture of SFA on LDL cholesterol concentrations from RCTs was the
best evidence available to conclude that an upper limit for the consumption of SFA contributes to
decrease the burden of chronic metabolic diseases, despite the different metabolic effects of SFA.
So, the same scientiﬁc evidence led to different conclusions on the recommendations to be given
for dietary SFA. One view was that dietary guidelines should be based on the metabolic effects of
nutrients, giving more weight to the physiological functions of individual SFA and less weight to
observed associations with clinical disease endpoints or biomarkers of disease. In that case, butyric
acid should be grouped with ‘probiotics’ and dietary ﬁbres, myristic acid with n-3 long-chain PUFA,
stearic acid with oleic acid, and palmitic acid with linoleic acid, sugars, total energy and alcohol when
providing nutritional recommendations for populations. The second view advocated to recommend
replacement of food sources high in SFA by food sources rich in cis-unsaturated fatty acids for CHD
prevention, rather than providing guidelines for total SFA form all food sources or for individual SFA,
which rarely occur alone in foods.
2.2. Towards diets focusing on whole foods and overall eating patterns
An historical perspective of nutrition concerns in high-income countries was given. Nutrition became
a matter of national security in the ﬁrst half of the 1900s. That was the time when all known vitamins
were isolated, synthesised and proved to be at the basis of severe deﬁciency diseases that could be
cured with food or synthetic sources. Establishing Recommended Dietary Allowances (RDA) for
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vitamins, some minerals, protein and energy became a priority during the Great Depression and World
War II. In the 1960s and 1970s, efforts were made to ensure an adequate supply of energy and
selected micronutrients to the global population, such as through increased agricultural production of
starchy staples and also through food fortiﬁcation and supplementation. World-wide, the debate
around fat and sugars as responsible nutrients for CHD high-income countries, and of energy and
protein shortage as the cause of infant and child malnutrition in low-income countries, took centre
stage. In the 1980s and 1990s, the interest shifted from nutrient deﬁciency diseases to chronic disease
prevention in high-income countries.
This new challenge was approached with the single nutrient, reductionist approach that had been
so successful for nutrient deﬁciency diseases. Therefore, reductions of either energy, fat, SFA, trans-
fats, sodium or sugar intakes were proposed at different points in time to face diseases that are
multifactorial and are inﬂuenced by complex characteristics of foods and diet patterns through
different metabolic pathways. Single nutrient emphasis may be appropriate for additives such as salt,
industrial trans-fats and added sugars in beverages, which have been successfully reduced in foods
through reformulation and these measures could contribute to CVD prevention. A reduction in the
sugar content of beverages has also been effectively pushed forward in some countries through
taxation, which could limit their intake of empty calories particularly by children and adolescents and
eventually contribute to lower weight gain and improved metabolic health. However, there was
agreement among the experts that, beyond additives, the relationship between diet and health is
complex, and so the proposed solutions should probably reﬂect that complexity. For example, instead
of tackling one metabolic pathway at a time, focusing on single nutrients with potential adverse health
effects (e.g. total SFA reduction to lower LDL cholesterol, total calorie restriction for weight loss), more
attention should be paid to whole foods and their complex health effects. Foods represent mixtures of
nutrients that can affect metabolic pathways in very different ways. In some cases, the presence of
certain nutrients in high quantities (e.g. n-3 PUFA, dietary ﬁbre) may be as important as the low
content of other nutrients (e.g. sodium, SFA) to achieve beneﬁcial health effects. For example,
promoting consumption of fruits and vegetables, whole grains and ﬁsh could be more effective in
tackling obesity and disease prevention than restricting fat intake through consumption of low-fat
products, which can be high in added sugars, starch and salt.
In the same line, modiﬁcation of consumer behaviour for chronic disease prevention through
labelling single nutrients could be appropriate in some instances mostly for additives (e.g. for salt
reduction, to limit intake of SFA or trans-fats, to decrease added sugar intake from beverages), but
otherwise food choices based on the content of single macronutrients could be unrelated to or even
adverse for health. Similarly, the conventional view that energy balance (understood as energy ‘in’
minus energy ‘out’) is the main aspect to consider for obesity and chronic disease prevention is
increasingly controversial: there is increasing evidence that certain foods and diets can signiﬁcantly
modify the metabolic risk proﬁle without major changes in body weight, and that long-term weight
loss is not necessarily achieved by selecting foods on the basis of their energy content only.
2.3. Food innovation and consumer behaviour
Consumers in post-industrial societies have evolved along with urbanisation, changes in the food
supply chain, technological developments and the emergence of the digital world.
In times of shortage, the nutritional information provided in food labels was a tool to meet
minimum nutrient requirements and be in good health. Today, the interest of consumers in food goes
beyond clinical nutrient deﬁciencies and food safety, extending to chronic diseases, personal values
such as social justice and the future of the planet. Sustainability, social welfare and animal welfare
drive food choices more than ever before (e.g. fair trade, vegetarian, local, organic). Health concerns
have also changed, together with the concept of health beneﬁt, in relation to food. For example,
gluten-free or lactose-free products are food choices that go beyond the treatment of coeliac disease
or lactose intolerance; gut health, sports performance and alertness are most looked for in food by the
young.
Consumers have also shifted their interest from nutrients to popular diets (e.g. vegan, palaeo,
ketogenic) and personalised nutrition, and from ‘what I think is good for me’ to ‘what I know is good
for me’. The new generations are more interested than ever before in nutrition, but are also highly
exposed to misinformation and confusion. As an example, the proactive approach of people to their
health has fostered the proliferation of home test kits, motivating individual decisions on food choices
and avoidances, the scientiﬁc basis of which is disputable.
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Traditional (price, taste and convenience) and new (health, safety, societal impact, experience, trust
and sustainability) purchase drivers offer both challenges and opportunities to reinforce current food
dietary guidelines. Still, it is important to understand the paradoxical impact that food labelling can have
on consumer choices. Labelling of low-fat and low-energy foods could lead to over-consumption if these
foods are perceived as healthier, while healthier foods can be rejected as found to be less tasty and more
expensive. In this context, identifying the behavioural barriers to move from ‘knowing’ to ‘doing’ is of
paramount importance. For example, fruits and vegetables could be promoted through values (natural,
simple, ﬂexible, healthy), but they also need to be cheap and convenient to increase consumption.
The food industry is trying to meet consumer expectations (e.g. for a reduced use of food additives
and food processing) and manufacture healthier foods (e.g. with less sugar, salt and SFA; with more
ﬁbre) through reformulation. However, achieving these targets while maintaining an acceptable price,
taste and convenience of the ﬁnal product was presented as a major challenge.
2.4. Towards a multidisciplinary solution
The panel discussion included the need to adapt nutrition recommendations, nutrition education,
food information to consumers and food policies to the era of digital nutrition and chronic disease
prevention.
Healthy diets are made of foods with very different nutrient proﬁles that, in combination, can affect
metabolic pathways in different ways. Promoting the consumption of foods with beneﬁcial effects on
health, as well as discouraging consumption of other foods that may be unhealthy if consumed in
excess, requires the simultaneous implementation of multiple strategies that are likely to fail in
isolation. Healthy diets need to be not only nutritious, but also tasty, sustainable, socially acceptable,
affordable and adaptable to individual values and preferences.
Taxation of some foods to discourage consumption should be accompanied by subsidies on other
foods to achieve the opposite. This should probably be coupled with sister measures on food
availability and achievable reformulation targets for the food industry. Nutrition labelling should be
meaningful health wise and easy to interpret to support individual food choices. It was suggested that
the ratio of unsaturated to saturated fats, the ratio of sugars and reﬁned starches to ﬁbre, and
possibly the ratio of sodium to potassium could be informative for chronic disease prevention. Finally, a
better understanding of the drivers for food choices and of the barriers for long-term changes in
dietary habits could offer great opportunities to update nutrition messages and build effective
communication with consumers of the digital era.
3. Conclusions and recommendations
The discussion held at this session of the conference provided perspectives on the several factors
that are impacting and will inﬂuence the future of nutrition sciences. As outcome of the session, the
following recommendations should be considered:
• Policies for chronic disease prevention should consider speciﬁc foods and diets in addition to
single nutrients.
• Conduct large controlled trials of complex interventions such as speciﬁc foods and whole
dietary patterns and composite chronic disease outcomes to better inform such policies.
• Anticipate the impact of socio-demographic and consumer trends on food availability, product
reformulation and dietary patterns;
• Gather understanding on the barriers that prevent consumers from complying with science-
based dietary guidelines and recommendations and foster research on new approaches for
trusted public communication on nutrition;
• Gather evidence on effective systems level change (multifaceted strategies) to drive
behavioural changes in dietary habits.
• Promote continuous engagement of policy makers, risk assessors, food industry, NGOs,
academia and the society as a whole to tackle the epidemic of obesity, diabetes and heart
disease in modern societies.
Abbreviations
CHD coronary heart disease
CVD cardiovascular disease
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LDL low-density lipoprotein
PUFA polyunsaturated fatty acid
RCT randomised controlled trial
RDA Recommended Dietary Allowances
SFA Saturated fatty acids
SSB sugar-sweetened beverage
T2D type 2 diabetes mellitus
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